Lupin receives final approval for Fluocinonide Topical Solution

Capital Market 

From USFDA

has received final approval for its Fluocinonide Topical Solution USP, 0.05% from the United States Food & Drug Administration to market a generic version of County Line Pharmaceuticals, LLC's Fluocinonide Topical Solution USP, 0.05%.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)